Podcasts about cardiovascular diseases

What is a nurse scientist, and what is the difference between one that is PhD-prepared versus DNP-prepared? Guest Dawn Aycock, PhD, RN, ANP-BC, FAHA, FPCNA, FAAN, shares about the importance of nurse engagement in research, and how to get involved, no matter your role or location.Related PCNA Resources:Presenting Your Work: Call for Abstracts: https://pcna.net/events-news/cardiovascular-nursing-symposium/call-for-abstracts/Empowering CV Nurses to Engage in Clinical Research (article): https://pcna.net/news/empowering-cardiovascular-nurses-to-engage-in-clinical-research/Clinical Research: Engaging with the Community (podcast): https://pcna.net/podcast/clinical-research-engaging-with-the-community/About Research and Evidence-Based Practice (article): https://pcna.net/health-topics/research-and-evidence-based-practice/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

For new graduates of nurse practitioner programs, cardiovascular-focused knowledge and skills can be improved with additional professional development opportunities. Guest Michelle Alland, APRN, AGACNP-BC, MSN, FNP-C, AACC, describes postgraduate fellowships, local and national training options, onboarding, and the importance of mentorship from more tenured NPs.RELATED PCNA RESOURCES:Professional DevelopmentAwardsAbstractsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Most mayos, salad dressings and chips “made with 100% avocado oil” fail test; Borderline cholesterol—will a coronary calcium scan help decide whether a statin is warranted? Aged Garlic Extract for blood pressure; Immune benefits of BWH Beta Glucan. 

Managing High Homocysteine with MTHFR Variants and the Role of Vitamin C in Brain Aging: Registered dietitian nutritionist Leyla Muedin discusses MTHFR genetic variants (C677T and A1298C), their links to impaired methylation, homocysteine, SAMe, mood issues, migraines, vitamin deficiencies, and pregnancy complications, noting many people are asymptomatic and some feel worse on methylated B vitamins and do better on standard formulations. Responding to a listener with C677T, high homocysteine, and borderline methylmalonic acid, she reviews optimal homocysteine targets and outlines other causes of elevated homocysteine such as hypothyroidism/subclinical hypothyroidism, kidney failure, obesity, hypertension, diabetes, smoking, inactivity, and medications (atorvastatin, methotrexate, fenofibrate). She suggests checking these factors, considering absorption issues (intrinsic factor) for B12, and trialing SAMe and more trimethylglycine, with possible pharmacologic folate if needed. She then summarizes an observational Japanese study (n=2,044 adults >64) linking lower plasma vitamin C to reduced gray matter and weaker default mode network connectivity, and notes diet and blood sugar can affect vitamin C status.

Hosts: Ed Jones (Owner – Nutrition World) & Clint Powell A variety of topics to living a healthy life Presented by: Nutrition World www.nutritionw.com Broadcasting from the Nooga Dentistry Studio www.noogadentistry.com Production of: Whitfield Media Group www.vitalhealthradio.com Title: Beyond Cholesterol: The Heart Health Markers That Matter [0:00:00] – Intro: Lettuce Contamination, Social Media & Local Business Impact Discussion of “fear of lettuce,” limited to 15 states (not Tennessee) How social media amplifies food scares Local “Build a Salad” restaurant going out of business and timing around lettuce scare [0:04:39] – Back-to-School Immune Support: Oral Probiotics & Iodine Nasal Spray Back-to-school season and rise in colds/sicknesses Oral probiotics for kids: oral microbiome, throat/sinus benefits Iodine nasal spray for parents and teachers: safety, use during school/gym, personal routines of Ed and Clint [0:08:04] – Supplement Industry & Big Pharma Buyouts Thorne bought by Procter & Gamble for $3.8B History of pharma mocking “granola/hippie” supplement culture, now buying brands Many acquired supplement brands failing under pharma ownership Difference between pharma customers and nutraceutical users (education, mindset) Nutrition World's preference for privately owned brands [0:14:00] – Life Lessons from Flying & Racing: Doing the Hard but Right Thing Ed's story: practicing engine-out landings, re-learning best glide speed Insight: sometimes you must “point the nose down” (do the counterintuitive hard thing) to survive Clint's race-car analogy: “you go where you look” – look down the track, not at the wall [0:18:01] – Food Label Claims: Olive Oil vs. Avocado Oil Products UC Davis testing of products “made with olive oil” – most passed authenticity tests Avocado-oil-labeled products often failing purity tests Takeaway: be more skeptical of “made with avocado oil” claims [0:18:31] – Prostate Cancer & “Treating the Terrain,” Not Just the Tumor Dr. Gio (prostate-focused naturopath): focus on the ground cancer grows in Historical context from Stephen Paget's work on tumor “soil and seed” Lifestyle “soil-building” recommendations: Resistance training, walking 150 minutes/week Waist circumference < half your height Sleep, stress reduction, nutraceuticals, nutrient-dense diet [0:21:58] – Multivitamins, Carotid Stenosis & Functional Benefits COSMOS study: Centrum multivitamin and patients with carotid narrowing Reported improvements in physical function (walking, climbing stairs) and symptoms (shortness of breath, fatigue) Ed's extrapolation: better-designed multis (True Grace, Life Extension, etc.) likely offer even more benefit [0:22:30] – Post-Infectious Cough: Honey + Instant Coffee vs. Prednisone Double-blind RCT comparing: Honey + instant coffee paste Prednisone Guaifenesin Honey + instant coffee dramatically outperformed prednisone in reducing persistent cough frequency Discussion of guaifenesin's role, safety, and its regulatory history in health food vs. pharmacy channels [0:30:12] – Prednisone, COVID & Anxiety: Personal Case Story Guest Dr. Curt Dearing shares: Followed COVID protocol including prednisone Developed severe, prolonged anxiety afterward (twice) Realization that prednisone triggered it Ed's summary of prednisone side effects: bone loss, cataracts, muscle wasting, weight gain; okay short term, risky long term [0:33:30] – Cardiovascular Disease, Statins, & New Drug Lifendra (PCSK9 Inhibitor Pill) CV disease framed as leading cause of death for most people Introduction of Lifendra (oral PCSK9 inhibitor, from Merck) as “breakthrough” LDL-lowering drug Comparison with Repatha (injectable PCSK9 inhibitor) Curt's key points: Lifendra lowers LDL but does not show reduction in cardiovascular death, heart attack, or stroke (per Merck's own wording so far) Repatha's trial data: minimal impact on non-fatal events; no reduction in CV deaths vs. placebo Very high cost (~$300+/month out of pocket; heavy insurance burden) Critique of LDL obsession in cardiology Need to ask: Why is the cardiovascular system inflamed and oxidized? Ed & Curt's “terrain” model: Bad inputs: ultra-processed food, toxins, poor sleep, chronic stress, lack of sun/movement Missing inputs: nutrient-dense foods, minerals, omega-3s, organ meats, sunlight, sleep, movement Example of amlodipine: lowers BP numbers but may increase arterial calcification (calcium channel blocker) For people unwilling to change lifestyle, drugs may offer marginal benefit—but not true health [0:41:05] – Curt's Book & Lab Markers That Matter More Than LDL-C Curt's book: “Beyond Cholesterol: The Ultimate Guide to Testing and Supplements for Heart Health” Emphasis on better markers: ApoB, LDL particle size/number, calcium score, etc. Book's Amazon performance briefly noted (new release bestseller in its category) [0:44:32] – Alternatives to Statins & PCSK9s: Bergamot & Lifestyle Curt's hierarchy: Lifestyle (diet, exercise, stress, sleep) Targeted supplements like bergamot (citrus extract): lowers harmful particles such as ApoB and supports “good” LDL function Only then consider pharmaceuticals, and very selectively Skepticism about recommending Lifendra at all; strong bias toward non-drug approaches [0:45:28] – Dr. Wolfson, Mold, and Cardiovascular Terrain Ed & Curt's respect for Dr. Jack Wolfson, “The Natural Heart Doctor” Mention of mold as a major, under-recognized driver of cardiovascular disease Reference to Dr. Wolfson's educational resources and upcoming podcast plans [0:48:04] – Key Takeaways on Lifendra & Heart Prevention Strategy Lifendra will not fix: seed oils, glyphosate exposure, mold, bad sleep, chronic stress Terrain-building priorities: Real food, omega-3s, sunlight Toxin reduction Mitochondrial support Foundational supplements Contrast: drugs = band-aids with side effects; nutraceuticals = “side benefits” when used correctly [0:52:28] – Wrap-Up Ed mentions Sprouts selling lab-grown meat and his strong opposition Update on Oura Ring: now tracking nighttime blood pressure and importance of BP dipping Listener story: young man post–heart surgery credits Nutrition World's education and support with changing his life Final thanks to Dr. Dearing and closing outro  The post Radio Show / Podcast – August 9, 2026 first appeared on Vital Health Radio.

Heart disease remains the leading cause of death worldwide, yet many cardiovascular events occur in people whose cholesterol levels and routine cardiac tests appear completely normal. In this episode, I sit down with Dr. Sanjay Bhojraj, an interventional cardiologist and  founder of the Integrative Heart Institute, to explore why preventing heart disease requires looking far beyond traditional risk factors. Together, we discuss the Integrative HEART Framework, a comprehensive approach to cardiovascular prevention that considers inflammation, metabolic health, mitochondrial function, hormones, nervous system regulation, sleep, environmental toxins, and advanced diagnostics. Dr. Bhojraj also explains how wearable technology, precision imaging, genomics, and lifestyle medicine are transforming the future of heart care by identifying risk years before symptoms develop. If you're looking to better understand your cardiovascular health, prevent disease before it starts, and discover how integrative medicine is reshaping heart care, this conversation is a must-listen. Key takeaways: Cardiovascular health requires a comprehensive approach that goes beyond monitoring cholesterol and blood pressure; lifestyle, metabolic health, and stress play crucial roles. Integrative Heart Framework (HEART): Hormone optimization, Energy regulation, Autonomic nervous system healing, Rest and recovery, and Toxin reduction. Hormones and metabolism significantly affect heart health, and therapies like testosterone replacement can be beneficial. New diagnostic methods such as coronary CT angiograms are pivotal for assessing soft plaque and preventing heart attacks. Simple lifestyle changes often outperform complex medical interventions in maintaining long-term heart health.   More About Dr. Sanjay Bhojraj: Dr. Sanjay Bhojraj, MD, IFMCP is an interventional cardiologist and leader in precision, functional, and integrative cardiovascular medicine. After nearly two decades performing life-saving cardiac procedures—including coronary stents, structural heart interventions, and emergency heart attack care—he began asking a different question: Why are so many people developing heart disease in the first place? Today, Dr. Bhojraj is the founder of the Integrative Heart Institute, where he combines the best of conventional cardiology with functional medicine, genomics, advanced imaging, lifestyle medicine, and emerging longevity science to identify and address the root causes of cardiovascular disease before catastrophic events occur. He is a Certified Practitioner with the Institute for Functional Medicine (IFM), serves as faculty for both IFM and the Academy for Anti-Aging Medicine (A4M), and completed his cardiology and interventional cardiology training at Henry Ford Hospital after graduating from Indiana University School of Medicine. Dr. Bhojraj developed the Integrative HEART Framework—a comprehensive model that expands cardiovascular risk assessment beyond cholesterol and blood pressure to include hormones, mitochondrial health, autonomic function, recovery and sleep, environmental toxins, inflammation, metabolism, and precision diagnostics. His mission is to help patients build resilient cardiovascular health rather than simply manage disease after it appears. He is also host of The Curious Cardiologist podcast, where he interviews leading experts at the intersection of cardiology, functional medicine, longevity, and human performance. Website Instagram Connect with me! Website Instagram Facebook YouTube

Precision Hormone Health: Testosterone, Menopause, Muscle, Sleep, and Proactive Longevity: Endocrinologist Dr. Florence Comite details her book “Invincible: Defy Your Genetic Destiny to Live Better, Longer” and her precision-medicine approach to proactive longevity. She discusses testosterone decline beginning in the 30s in both sexes, stress-related low T (including in special forces), and testosterone's roles in energy, cognition, motivation, muscle, bone, and chronic disease risk. Comite argues genes are a “draft” and health destiny can be altered through epigenetic-like choices, individualized data, and early monitoring. For women, she emphasizes estrogen, progesterone, and testosterone in perimenopause/menopause, preferring bioidentical hormones and criticizing WHI's use of Premarin/Provera and older participants. She covers osteoporosis prevention, muscle as an “organ of longevity,” protein intake, resistance training, continuous glucose monitors for individualized diet, sleep quality tracking via wearables, and selective use of DHEA, pregnenolone, growth hormone pathways, and peptides with attention to sourcing and risk.

Approximately 95% of SCAD cases (spontaneous coronary artery dissection) occur in women--even young women who do not have typical cardiovascular risk factors. Guests Eileen Handberg, PhD, ANP-BC, FAHA, FACC, FPCNA, and Maggie Teliska describe SCAD from both a clinical and patient standpoint: symptoms, diagnosis and misdiagnosis, treatments, advocating for yourself, and the importance of the SCAD registry in moving the science forward.Related resources:scadalliance.orgwomenheart.orgHeberden's symptom description from 1800s: https://pmc.ncbi.nlm.nih.gov/articles/PMC2989494/PCNA Article: Cardiovascular Health in Women: https://pcna.net/news/cardiovascular-health-in-women-beyond-the-basics/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us Fan MailFor years, women have been told that weight gain, irregular cycles, insulin resistance, elevated cholesterol, fatigue, and hormone imbalances are separate problems requiring separate solutions.But what if they're all connected?In this episode, Cody sits down with Dr. Sirisha Vadali, board-certified cardiologist, advanced lipidologist, and Program Director of HonorHealth's Cardiometabolic Program, to explore the growing understanding of women's metabolic health and why experts are rethinking the way we approach conditions like PCOS.Dr. Vadali explains why many experts now support the term PMOS (Polyendocrine Metabolic Ovarian Syndrome), recognizing that this condition affects far more than the ovaries. Together, they discuss how hormones, insulin resistance, inflammation, metabolism, and cardiovascular health are deeply interconnected—and why understanding that bigger picture can completely change a woman's approach to her health.Whether you've struggled with weight loss, elevated cholesterol, insulin resistance, irregular cycles, or simply feel like your symptoms haven't been taken seriously, this conversation offers both validation and practical hope.In This Episode You'll Learn: Why many experts are advocating for the shift from PCOS to PMOS  The surprising relationship between hormones, insulin resistance, and metabolism  Why cardiovascular health should be part of every woman's hormone conversation  Early signs of insulin resistance that often go unnoticed  Why women are frequently dismissed or misdiagnosed  How inflammation impacts hormones and long-term health  What cholesterol really tells us about metabolic health  Lifestyle habits that have the greatest impact on insulin sensitivity  Why quick fixes rarely create lasting results  Practical ways to reduce future cardiometabolic risk Key TakeawayWomen's health isn't just about hormones.It's about understanding how hormones, metabolism, inflammation, insulin, and cardiovascular health all work together.When we stop treating symptoms in isolation and begin supporting the whole system, we create a much stronger foundation for long-term health.About Our GuestDr. Sirisha Vadali is a board-certified cardiologist, advanced lipidologist, and Program Director of Honor Health's Cardiometabolic Program. Having cared for more than 120,000 patients, she is passionate about prevention and helping women better understand the connection between metabolic health, hormones, cardiovascular disease, and longevity.Connect with Dr. Sirisha VadaliIf you'd like to learn more from Dr. Vadali or connect with her work, you can find her here:

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into the latest groundbreaking advancements, strategic corporate maneuvers, and pivotal regulatory updates shaping this dynamic industry landscape. Starting with some exciting news, Scribe Therapeutics has successfully closed its initial public offering, raising a significant $129 million. This substantial funding will drive forward their pioneering work in gene editing technologies, particularly focusing on therapies for cardiovascular diseases and atherosclerotic cardiovascular disease (ASCVD). By leveraging CRISPR technology, Scribe Therapeutics is positioned at the forefront of developing transformative treatments for both rare and common diseases. This advancement could potentially revolutionize how these conditions are managed, offering new hope for patients worldwide. On the regulatory front, Amgen is actively working to maintain its competitive edge in the U.S. market by submitting a comprehensive data package to the FDA for its drug Tavneos. This strategic move highlights the competitive nature of the pharmaceutical landscape where maintaining market access and drug positioning is crucial. Additionally, an FDA panel has recently endorsed lifting restrictions on four peptides, a decision that could significantly enhance therapeutic options in wound healing and autoimmune diseases through compounding pharmacies. This shift indicates a broader acceptance of peptides' therapeutic potential, which are increasingly being explored for their targeted therapy applications. In clinical trial news, Meiji Seika Pharma has reached a significant milestone with its combination therapy involving HBI-8000 and nivolumab. The therapy has successfully met the progression-free survival endpoint in a Phase 3 trial for advanced melanoma. This approach combines an epigenetic immunomodulator with a PD-1 inhibitor, representing a strategic method to harness immune system modulation for cancer treatment. Such advancements highlight ongoing innovations within oncology therapeutics and emphasize opportunities for improved patient outcomes through novel treatment combinations. However, not all clinical trials meet success. Sanofi's recent decision to halt Phase 3 development of amlitelimab for atopic dermatitis due to insufficient data serves as a reminder of the inherent challenges in drug development. Similarly, Ipsen's Bylvay did not meet its primary endpoint in a pivotal trial for biliary atresia patients post-Kasai surgery. These setbacks highlight the complexities involved in translating scientific discoveries into viable therapeutic options and underscore the unpredictable nature of drug development. Shifting to corporate strategies, Roche has decided to discontinue its development of an obesity asset, acmopatide, while placing support behind another candidate, enicepatide. This decision reflects dynamic prioritization within pipelines as companies navigate scientific data alongside market demands. Meanwhile, Fresenius has launched a €200 million corporate venture capital fund targeting innovations across biopharma, medtech, and digital care sectors. This move aligns with an increasing trend towards supporting early-stage innovations addressing unmet medical needs. In mergers and acquisitions news, Scancell's acquisition of Neophoria Therapeutics via reverse merger showcases strategic maneuvers within the sector aimed at securing financial stability and market presence through listings such as on NASDAQ. These activities illustrate broader industry trends where companies seek growth through strategic partnerships and acquisitions to enhance technological capabilities and market reach. In oncology developments, GSK has achieved a landmark FDA approval for Jideytro following its acquisition of Nuvalent. This milestone underscores the strategic importance of mergers and acquisitions in achieving rapid growth and diversification in oncology pipelines. The quick payoff from this deal highlights how targeted acquisitions can accelerate therapeutic advancements. Turning our attention to HIV prevention strategies, Merck is expanding access to its investigational PrEP pill Alimatravir through voluntary licensing agreements even before regulatory approval. This proactive strategy mirrors Gilead's successful model and emphasizes the industry's shift towards accessibility and patient-centric approaches. Finally, technological advancements continue reshaping industry practices with AI integration into incentive compensation models being explored by companies like Novartis in collaboration with consulting firms such as ZS Associates. These efforts are part of a larger digital transformation within the industry aimed at enhancing operational efficiency and decision-making processes. As we wrap up today's insights, it's clear that these developments highlight an era where scientific innovation intersects with strategic business decisions and regulatory frameworks. The implications for patient care are profound as these efforts translate into more effective therapies with potential impacts on treatment accessibility, efficacy, and personalization. As the industry continues to evolve rapidly amidst scientific breakthroughs and regulatory changes, maintaining a balance between innovation, regulation, and market dynamics will be crucial for sustaining growth and improving health outcomes globally.Support the show

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the most exciting scientific breakthroughs and regulatory developments that are shaping the future of healthcare. Eli Lilly's retatrutide, a promising small molecule GLP-1 receptor agonist, has achieved significant results in Phase 3 trials, leading to an impressive 22.6% weight loss in patients with obesity and cardiovascular disease. This breakthrough underscores the potential of GLP-1 receptor agonists in transforming treatment paradigms for metabolic disorders. The drug's ability to target metabolic pathways associated with obesity and type 2 diabetes could herald a new era in managing these conditions, offering hope for millions struggling with obesity—a major risk factor for cardiovascular diseases. In oncology, Johnson & Johnson has unveiled remarkable results with its combination therapy of Tecvayli (teclistamab) and Talvey (talquetamab), achieving an 89% reduction in disease progression risk for multiple myeloma patients during a Phase 3 trial. This bispecific antibody approach targets BCMA and GPRC5D, representing a significant advancement in treating this challenging hematological malignancy. Such efficacy could set a new standard for multiple myeloma treatment strategies, enhancing patient outcomes considerably. Meanwhile, GSK has made strides with FDA approval of Jideytro (zidesamtinib) for ROS1-positive metastatic non-small cell lung cancer. This small molecule kinase inhibitor targets the ROS1 mutation, providing a targeted therapeutic option that aligns with the progress in precision medicine—offering treatments based on patients' genetic profiles. On the regulatory front, the passage of FDA Modernization Act 3.0 by the House reflects a shift towards more ethical preclinical testing methods by updating outdated animal testing regulations. This legislative change could expedite drug development timelines and improve the translation of preclinical findings into clinical success—an encouraging step forward for the industry. In China, Takeda's Orzeyful (oveporexton) received approval as the first ox2r agonist for narcolepsy type 1 treatment. This approval marks advancements in addressing neurological conditions through novel mechanisms targeting orexin receptor pathways. Similarly, Haisco Pharmaceutical's Ciprocopan has been approved as an oral complement factor B inhibitor for paroxysmal nocturnal hemoglobinuria (PNH), offering a more convenient treatment option compared to existing therapies. AstraZeneca's Etcamah (camizestrant) gained EU approval following its success in Phase 3 trials for estrogen receptor-positive, HER2-negative advanced breast cancer. As an oral selective estrogen receptor degrader (SERD), it presents an innovative approach to targeting ESR1 mutations and could be combined with CDK4/6 inhibitors to enhance therapeutic efficacy further. On the strategic collaboration front, partnerships like those formed by Arcus Biosciences with Aveo Oncology and Summit Therapeutics exemplify efforts to advance drug discovery capabilities, particularly in kidney cancer treatments. These collaborative approaches reflect a broader trend in oncology therapeutics development. Financial investments are also fueling growth within the sector. Mentari Therapeutics secured $200 million to propel its migraine prevention biologics pipeline forward, highlighting confidence in biologic treatments for neurological disorders. Beone Medicines has committed $300 million to expand manufacturing capabilities, demonstrating ongoing investment in infrastructure to support future drug production demands. In summary, these developments illustrate significant scientific advancements and regulatory progress within the pharmaceutical and biotech industries. The implications are profound: improved patient care through innovative therapies, enhanced precision medicine approaches tailored to genetic mutations, and accelerated drug discovery processes facilitated by evolving regulatory frameworks. As these trends continue to evolve, they promise to reshape patient outcomes and redefine standards across various therapeutic areas. Thank you for tuning into Pharma Daily today. Stay informed as we continue to bring you updates on cutting-edge advances that are transforming healthcare worldwide.Support the show

Dr. Gary McGowan drops in to share a masterclass on cardiovascular disease and its major risk factors, including:The relationship between cholesterol and cardiovascular diseaseWhy LDL cholesterol is importantWhat causes LDL cholesterol to riseThe dietary factors that can increase LDL cholesterolNavigating misleading claims about LDL from the carnivore diet communityWhy elimination diets can appear to improve someone's healthThe relationship between obesity and cardiovascular diseaseWhy not all fat storage in the body is associated with the same level of disease riskVisceral fat, BMI, and the personal fat thresholdWhy cardiovascular risk accumulates over timeThe role of genetics in cholesterol and blood pressureWhat causes high blood pressureThe role of dietary sodium in hypertensionThe most important lifestyle behaviours for lowering cardiovascular disease riskHow to screen for atherosclerotic plaque buildup in your arteriesCoronary artery calcium scans and CCTA imagingWhether caffeine and energy drinks increase the risk of heart problemsAnd much moreFollow Gary on Instagram:@drgarymcgowanCHAPTERS01:31 Cholesterol and Heart Risk04:50 Why LDL Rises06:23 Diet Drivers of LDL09:31 Coffee and Cholesterol10:32 Exercise and Lipids12:19 Carnivore LDL Debate18:32 Elimination Diet Reality21:48 Obesity and Heart Disease26:26 Visceral Fat and BMI31:15 BMI Reality Check32:24 Personal Fat Threshold32:46 Obesity Over Time33:58 Cumulative Risk Model34:58 Blood Pressure Drivers36:04 Salt and the Modern Diet38:21 Lifestyle Risk Pillars38:53 Heart Plaque Screening41:32 Calcium Scans Explained44:33 CCTA for Soft Plaque48:17 Caffeine and Heart Risk53:14 Energy Drink Extremes55:21 Where to Find Gary57:34 Final Wrap-UpSUPPORT THE SHOWIf this episode helped you better understand cholesterol, blood pressure, or cardiovascular disease risk, you can support the show by:Subscribing and checking out more episodesSharing it on social media — tag me and I'll respondSending it to someone who is confused about cholesterol, blood pressure, or heart healthFOLLOW ANDREW COATESInstagram: @andrewcoatesfitnesshttps://www.andrewcoatesfitness.comPARTNERS AND RESOURCESRP STRENGTH APPUse code COATESRP:https://www.rpstrength.com/coatesJUST BITE ME MEALSUse code ANDREWCOATESFITNESS for 10% off:https://justbitememeals.comMACROSFIRST – FREE PREMIUM TRIALDownload MacrosFirst and during setup you'll be asked:“How did you hear about us?”Type in the code: ANDREWKNKG BAGS – 15% OFFhttps://www.knkg.com/Andrew59676VERSA GRIPPShttps://www.versagripps.com/andrewcoatesTRAINHEROIC – FREE 90-DAY TRIALComplete these two steps:Go to:https://www.trainheroic.com/liftfreeReply to the email you receive — or email trials@trainheroic.com — and let them know Andrew sent you.L1 BIOMECHANICS AND ASSESSMENT COURSEUse code COATES:https://pro.activelifeprofessional.com/assessmentworkshopevents

Quality improvement projects can be done in just about any setting--but what does the process look like?Guest Kate Lew, MSN, RN, FNP-C, shares her experience in the creation and completion of a QI project in her workplace. Learn about the steps and strategies that were used to identify the problem, access related data, and make recommendations for improvement.Resources:PCNA Abstracts: https://pcna.net/events-news/cardiovascular-nursing-symposium/call-for-abstracts/abstract-guidelines/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Professional development to improve nursing knowledge and skills occurs in a variety of forms. Learn from Sandra Klafter, BSN, RN, CV-BC, about her experience in preparing for the Cardiac-Vascular Nursing Certification (CV-BC) as well as her involvement in PCNA.CV-BC CredentialVolunteering with PCNASee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and Management

Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and Management

Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and Management

This week, I reviewed the latest on my Lyme treatment, which is not too bad, some antibiotics, herbs, and probiotics. Then we talked about the great vitamin K2, whose job is to direct calcium to your bones and away from places you don’t want it, like in your knees, kidneys, and arteries. Then on to […]

Is it safe to stop statins “cold turkey”? Can the supplement ingredient HMB counteract age-related muscle loss? Researchers may have discovered the key to development of a true fat-burning weight loss medication; Can a mammogram yield clues about cardiovascular risk? Their bottom line threatened by GLP-1 weight loss drugs, BIg Food tweaks portion sizes, adds spices and flavorings to pique blunted appetites; Vitamins A & D may improve lung health for asthma sufferers; When it comes to thyroid medication prescribing, treat the numbers or treat the patient? 

Dr. Klaper shares visual evidence that plaques melt away and angina resolves on a plant-based diet backed by clinical studies. #HeartReversal #PlaqueReduction #VeganCardio #HealthTalks

Advanced practice providers (APP) provide both quality care and leadership in structural heart interventions. Guest Caitlin O'Callaghan Reen, CNP, FACC, describes how to effectively work with patients and their support communities in shared decision-making for long-term, lifetime planning, and leadership within the structural heart team.Related PCNA CE Course: Structural Heart Interventions: What's New?See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Around 4% of the global population has aortic stenosis, and early identification is key to reducing strain on the heart and reducing morbidity and mortality. Guest Alicia White, MSN, RN, describes signs and symptoms, diagnosis, treatment, and follow-up care following procedures.Related PCNA CE course:Aortic Stenosis: An increasing risk for structural heart disease: https://pcna.net/course/aortic-stenosis-an-increasing-risk-for-structural-heart-disease/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Weniger als vier von 100. So wenige gingen ein Jahr später noch ins Fitnessstudio. Und das lag nicht daran, dass sie nicht wollten.Fitness-Gewohnheiten – ob gesundes Essen, Supplement-Einnahme oder regelmäßiges Training – spielen neurobiologisch in einer eigenen Liga. Am Anfang arbeitet Dein Gehirn gegen Dich. Am Ende dieser Folge weißt Du, warum, und mit welchen drei Strategien Du trotzdem dranbleibst.Du erfährst:Warum sich die ersten Wochen wie ein Kampf anfühlen, und wann sich das drehtWarum die „21-Tage-Regel“ nicht funktioniert – und wie lange Du wirklich brauchst3 simple Strategien, die in Studien zu >50% häufigerem Training führen.Los geht's. Und dann: dranbleiben.____________*WERBUNG: Infos zum Werbepartner dieser Folge und allen weiteren Werbepartnern findest Du hier.

Are your blood markers telling you and your doctor the whole story? Chronic inflammation is the silent driver behind nearly every major disease, and the good news is that your lifestyle choices decide the outcome. Don't wait for a life altering diagnosis to take action.In this episode of Salad With a Side of Fries, host Jenn Trepeck breaks down how blood markers move, how preventable diseases develop, and why epigenetics means your genes are not your fate. If you have ever felt like your health was out of your hands, this episode will change the way you think about your daily choices.What You Will Learn in This Episode:✅ Why chronic inflammation is considered the root cause of virtually every major illness and how oxidative stress accelerates disease progression in the body.✅ How epigenetics reveals that your lifestyle choices, not just your genetics, impact disease-related genes.✅ What specific blood markers to track for heart disease, type 2 diabetes, liver disease, and kidney disease, and realistic timelines for improving them.✅ How to advocate for yourself in a medical system still rooted in a prescription-first approach, and how to ask your doctor for the time and space to make disease prevention changes first.The Salad With a Side of Fries podcast, hosted by Jenn Trepeck, explores real-life wellness and weight-loss topics, debunking myths, misinformation, and flawed science surrounding nutrition and the food industry. Let's dive into real-life wellness and weight loss, including drinking, eating out, and skipping the grocery store.TIMESTAMPS:00:00 Preventable diseases don't have to be your story and what blood markers can and cannot tell you05:55 The most common diseases: heart disease, type 2 diabetes, and cancer and how they are linked to lifestyle choices06:46 Epigenetics explained: how your daily habits turn disease risk genes up or down17:21 Lifestyle choices, from gut health to the brain to the endocrine system, impact every organ system20:10 Oxidative stress and free radicals explained: the science behind chronic disease25:01 Lifestyle choices that support overall health rather than disease and healthcare 3.0, being your own advocate32:12 Discussion of food with no labels; vegetables, fruit and lean meat36:19 Movement as disease prevention: why sitting all day quietly drives chronic illness more than we realize41:06 Longevity, community, connection, sleep, and stress management as overlooked pillars of health42:05 Blood marker timelines: how fast insulin, A1C, cholesterol, and blood pressure respond to lifestyle changesKEY TAKEAWAYS:

Contraception Decision-making for Pre-menopausal Women with Cardiovascular Disease   Guest: Margaret Long, M.D. Host: Marysia Tweet, M.D., M.S.   This podcast discusses how to approach contraceptive counseling for premenopausal women with cardiovascular disease, emphasizing individualized decision-making based on pregnancy goals and medical risks. It highlights safer options—such as progestin-only methods and intrauterine devices—while cautioning against estrogen-containing contraceptives due to increased thrombotic risk. The discussion also reviews practical considerations for cardiologists, including managing contraception after cardiac events and coordinating care with specialists. Overall, it underscores that effective contraception is typically safer than pregnancy for patients with significant cardiac conditions   Topics Discussed: How do you approach contraception decision making in a patient with cardiac disease? Are some contraception options safer than others? Are those options just as effective? Will a specific method affect blood pressure or cholesterol? Are there other side effects to be aware of? What if a patient has an adverse event such as a heart attack or pulmonary embolus while on oral contraception? What is your approach to those patients? What are the most important lessons you would like to share with cardiovascular specialists?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded on: 23-January-2026  

How can nurses and other healthcare professionals help patients with diabetes and other cardiometabolic conditions reduce their risk of CVD? Join guests Joseph Saseen, PharmD, MNLA, FACC, CLS, and Emily Bankhead, MSN, FNP-BC, for a discussion about applying current guidelines for hypertension and glucose-lowering therapies and the importance of team-based care.Related Resources:2025 AHA/ACC High Pressure Guideline2026 Multi-Society CKM Guideline [released after this episode recording]PREVENT EquationsPCNA CE Course: Cardiometabolic Treatments for ObesitySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The intersection of risk factors for diabetes, obesity, hyperlipidemia, the liver, and the cardiovascular system is becoming increasingly evident, and so is the mult-system impacts of lifestyle and specific pharmacotherapies for prevention and treatment. Episode guests Joseph Saseen, PharmD, MNLA, FACC, CLS, and Emily Bankhead, MSN, FNP-BC, describe the positive impacts of healthcare professionals working collaboratively, and to the top of their scope of licensure, to effectively address multi-system disorders.Related Resources2026 Multi-Society CKM Guideline [released after this episode recording]PCNA CE Course: Cardiometabolic Treatments for ObesitySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“The quick and the dead”: 80+ “Supermovers” show slowed cognitive decline; Dietary polyphenols help overcome vascular effects of prolonged sitting; Pros and cons of ketamine therapy for depression; Time-restricted eating alters microbiome to promote weight loss; Magnesium—what research reveals about better sleep, stress resilience, and whole-body wellness.

Are light runs (Zone 2 runs) better than heavier workouts? Sophie goes on a semi-manic tangent in her most enthusiastic episode yet to answer whether less intense exercise might actually help your fitness level, aerobic threshold and mitochondrial efficiency. Also, Chris tells a funny marathon story and a viewer question tries to fact-check to the fact checkers on whether walking and running burn the same amount of energy.   Become a supporter of our show today either on Patreon or through PayPal! Thank you! http://www.patreon.com/thebodyofevidence/ https://www.paypal.com/donate?hosted_button_id=9QZET78JZWCZE   Email us your questions at thebodyofevidence@gmail.com.   Hosts:     Christopher Labos & Sophie Tseng Pellar Editor:    Robyn Flynn Researcher: Auriane Journet Theme music: “Fall of the Ocean Queen“ by Joseph Hackl Rod of Asclepius designed by Kamil J. Przybos Chris' book, Does Coffee Cause Cancer?: https://ecwpress.com/products/does-coffee-cause-cancer   Obviously, Chris is not your doctor (probably). This podcast is not medical advice for you; it is what we call information. References: 1.   Storoschuk, K. L., Moran-MacDonald, A., Gibala, M. J., & Gurd, B. J. (2025). Much Ado About Zone 2: A Narrative Review Assessing the Efficacy of Zone 2 Training for Improving Mitochondrial Capacity and Cardiorespiratory Fitness in the General Population: KL Storoschuk et al. Sports Medicine, 55(7), 1611-1624.  2.   Mølmen, K. S., Almquist, N. W., & Skattebo, Ø. (2025). Effects of exercise training on mitochondrial and capillary growth in human skeletal muscle: a systematic review and meta-regression. Sports Medicine, 55(1), 115-144. 3.   Inglis, E. C., Iannetta, D., Rasica, L., Mackie, M. Z., Keir, D. A., Macinnis, M. J., & Murias, J. M. (2024). Heavy-, severe-, and extreme-, but not moderate-intensity exercise increase V̇o 2max and thresholds after 6 wk of training. Medicine & Science in Sports & Exercise, 56(7), 1307-1316. 4.   McConell, G.K., Wadley, G.D., Le plastrier, K. and Linden, K.C. (2020), Skeletal muscle AMPK is not activated during 2 h of moderate intensity exercise at ∼65% in endurance trained men. J Physiol, 598: 3859-3870. https://doi.org/10.1113/JP277619 5.   Meixner, B., Filipas, L., Holmberg, H. C., & Sperlich, B. (2025). Zone 2 Intensity: A Critical Comparison of Individual Variability in Different Submaximal Exercise Intensity Boundaries. Translational sports medicine, 2025, 2008291. https://doi.org/10.1155/tsm2/2008291 6.   Harber MP, et al. Impact of Cardiorespiratory Fitness on All-Cause and Disease-Specific Mortality: Advances Since 2009. Progress in Cardiovascular Diseases 2017;60(1):11-20. PubMed 28286137 7.   Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women: A Meta-analysis. JAMA 2009;301(19):2024-2035. PubMed 19454641  

Episode 85 Part 2/2. Cardiovascular disease is often thought of as a heart problem, but its effects reach far beyond the cardiovascular system. In this episode, Dr. Gavin Guard explores the root causes of cardiovascular disease through a functional medicine lens, breaking down how chronic inflammation, metabolic dysfunction, nutrition, and lifestyle choices influence long-term heart health. You'll learn how cardiovascular disease develops, the warning signs to watch for, and the connection between factors like high blood pressure, cholesterol imbalances, insulin resistance, and overall wellness. Dr. Holthouse also discusses evidence-based strategies for reducing risk and improving healthspan through personalized care and preventive medicine. Whether you're looking to better understand your cardiovascular risk, support a loved one, or take proactive steps toward a healthier future, this episode provides practical insights and actionable takeaways grounded in current science. In this episode, you'll learn: What cardiovascular disease is and why it's so common How inflammation contributes to heart disease The relationship between cholesterol, blood pressure, and cardiovascular risk Why metabolic health plays a major role in heart health Functional medicine approaches to prevention and treatment Lifestyle strategies that support a healthy cardiovascular system Steps you can take today to reduce your risk of heart attack and stroke Stay tuned in for more conversations on functional medicine, preventive healthcare, longevity, and optimizing your health from the inside out!

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Trends in the Co-Occurrence of Alcohol Use and Cardiovascular Disease Among U.S. Adults, 1999 to 2023.

With Florian A Wenzl University of Zurich, Zurich - Switzerland, Alexander Lyon, Royal Brompton Hospital, London - UK and David Adlam, University of Leicester, Leicester - UK. Link to European Heart Journal paper Link to European Heart Journal editorial  

This month on Episode 85 of Discover CircRes, host Cindy St. Hilaire highlights articles featured in the May 22nd, June 5th and June 19th issues of Circulation Research. This Episode also features a discussion with Professor Katrin Schäfer, Dr Rajinikanth Gogiraju, and Dr Beichen Sun, about their study, Chronic Erythrocyte NO Production Accelerates Atherosclerosis by Increasing SMC De Novo Lipogenesis.   Article highlights: Larcher, et al. Cardiac Fibroblast Heterogeneity and Disease Huang, et al. Vascular Endothelial NOX1 Drives Obesity Atici, et al. Role of Sirtuin-1 in Murine Vasculitis Compendium on Lipoproteins and Cardiovascular Disease

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk about the latest health news. Dr. Marty shares details about a COVID-19 vaccine study that links to a lower risk of cardiovascular disease, as well as who should get the Alzheimer’s blood test.

Skin cancer comes from the sun. But so do many good things, according to author Rowan Jacobsen. Jacobsen talks with EconTalk's Russ Roberts about the health benefits of sunshine and makes the case for prudent sun exposure. Topics discussed include the "heliotherapy" movement that peaked in the early 1900s in response to rickets and tuberculosis, why diagnosing skin cancer is on the rise, and why yesterday's sunscreens may have done more harm than good.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-489 Overview: Join us as we discuss lipoprotein(a) testing—including when it adds value and when it may not. We review the evidence behind this increasingly requested cardiovascular risk marker, equipping you with the knowledge to counsel patients, understand current and emerging treatment options, and optimize evidence-based strategies to reduce overall cardiovascular disease risk. Episode resource links: Eur J Clin Invest. 2025 Oct 3:e70127. doi: 10.1111/eci.70127. Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147 Progress in Cardiovascular Diseases, 84, 2024, Pages 27-33, https://doi.org/10.1016/j.pcad.2024.05.007 Guest: Jillian Joseph, MPAS, PA-C   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-489 Overview: Join us as we discuss lipoprotein(a) testing—including when it adds value and when it may not. We review the evidence behind this increasingly requested cardiovascular risk marker, equipping you with the knowledge to counsel patients, understand current and emerging treatment options, and optimize evidence-based strategies to reduce overall cardiovascular disease risk. Episode resource links: Eur J Clin Invest. 2025 Oct 3:e70127. doi: 10.1111/eci.70127. Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147 Progress in Cardiovascular Diseases, 84, 2024, Pages 27-33, https://doi.org/10.1016/j.pcad.2024.05.007 Guest: Jillian Joseph, MPAS, PA-C   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

This episode equips nurses with practical tools to assess and manage patients with cardiometabolic risks like obesity, hypertension, and diabetes. Guests Yvonne Commodore-Mensah, PhD, MHS, RN, and Cindy Lamendola, MSN, NP, dive into the power of lifestyle changes to reduce these risks, while also breaking down the latest clinical guidelines and pharmacotherapies to keep your practice current and effective. Link to the Cardiovascular Nursing Certificate: https://pcna.net/career-development/cardiovascular-nursing-certificate/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This episode explores how translational research bridges the gap between scientific discovery and real-world patient care, and highlights the nurse's pivotal role in clinical trials. Tune in to guests Brittany Butts, PhD, RN, and Erin Ferranti, PhD, MPH, RN, FAHA, FPCNA, FAAN, to learn how you can champion research, from participation to publication, and drive meaningful change in healthcare.Link to the Cardiovascular Nursing Certificate here: https://pcna.net/career-development/cardiovascular-nursing-certificate/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cardiovascular disease is often thought of as a heart problem, but its effects reach far beyond the cardiovascular system. In this episode, Dr. Gavin Guard explores the root causes of cardiovascular disease through a functional medicine lens, breaking down how chronic inflammation, metabolic dysfunction, nutrition, and lifestyle choices influence long-term heart health. You'll learn how cardiovascular disease develops, the warning signs to watch for, and the connection between factors like high blood pressure, cholesterol imbalances, insulin resistance, and overall wellness. Dr. Holthouse also discusses evidence-based strategies for reducing risk and improving healthspan through personalized care and preventive medicine. Whether you're looking to better understand your cardiovascular risk, support a loved one, or take proactive steps toward a healthier future, this episode provides practical insights and actionable takeaways grounded in current science. In this episode, you'll learn: What cardiovascular disease is and why it's so common How inflammation contributes to heart disease The relationship between cholesterol, blood pressure, and cardiovascular risk Why metabolic health plays a major role in heart health Functional medicine approaches to prevention and treatment Lifestyle strategies that support a healthy cardiovascular system Steps you can take today to reduce your risk of heart attack and stroke Stay tuned in for more conversations on functional medicine, preventive healthcare, longevity, and optimizing your health from the inside out!

Cholesterol management, per new guidelines from the American College of Cardiology, is just one aspect of measures you can take to lower your risk for cardiovascular disease, the number one cause of death. Roger Blumenthal, a cardiologist at Johns Hopkins … What's involved in lowering your risk for cardiovascular disease? Elizabeth Tracey reports Read More »

When it comes to assessing your cardiovascular risk, your blood tells an eloquent story. It's not just cholesterol but several other factors that can be detected and measured that point toward or away from risk. Roger Blumenthal, a cardiologist at … What does a blood marker called lipoprotein A have to do with your risk for cardiovascular disease? Elizabeth Tracey reports Read More »

New guidelines for managing cholesterol levels have recently been released by the American College of Cardiology. Cardiologist Roger Blumenthal at Johns Hopkins chaired the committee that wrote the guidelines, and says that in reviewing the data it became clear that … Certain groups of people seem to be missing out when it comes to optimizing cardiovascular disease prevention, Elizabeth Tracey reports Read More »

It's been thought that once you have plaque in your arteries it stays there but that just isn't true. Dr. Melanie Icard is armed with the data to prove that lifestyle-based interventions with selected supplementation can reverse plaque in your arteries to the point of having zero evidence of any plaque at all. A great conversation you do not want to miss.    Connect with Dr. Icard: Website: www.drmelanieicard.com  Free Resource: cardiohealth.drmelanieicard.com/biohacked-heart-journey  Masterclass: cardiohealth.drmelanieicard.com/registration  Join our next live webinar: webinar.drmelanieicard.com/registration-page LinkedIn: linkedin.com/in/drmelicard  Instagram: instagram.com/drmelholistic  Facebook: facebook.com/drmelholistic  TikTok: tiktok.com/@drmel_holistic  YouTube: youtube.com/@Itsdrmel   Connect with Marian: https://www.roadtolivingwhole.com/meal-plans-for-therapeutic-diets/ https://www.roadtolivingwhole.com/about/ https://www.instagram.com/mairmitchell  

Menopause Management In Women with Cardiovascular Disease   Guest: Chrisandra Shufelt, M.D. Host: Marysia Tweet, M.D., M.S.   Listeners of this episode of “Interviews with the Experts” will gain a practical, evidence-based framework for managing menopausal symptoms in women with cardiovascular disease or elevated CVD risk. Through discussion of patient selection, menopause-specific cardiovascular risk factors, and the evolving data on hormone therapy. Listeners will leave better equipped to individualize care and counsel patients with confidence.   Topics Discussed: Treatment for menopause symptoms in women with risk factors for CVD  Appropriate candidates for hormone therapy Which cardiovascular risk factors are attributable to ovarian aging (menopause) versus chronological aging? What does the current evidence show regarding claims that menopausal hormone therapy prevents cardiovascular disease? How might the FDA's removal of the black box warning from menopausal hormone therapy labeling affect clinician prescribing practices and patient decision-making?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.   Recorded on: 15-January-2026

This episode is brought to you by Energy Bits. Most people are exhausted, inflamed, undernourished, and aging faster than they should be—and the modern food system is making it worse. While supplements promise quick fixes, few address the real root cause of chronic disease: mitochondrial dysfunction, oxidative stress, nutrient depletion, and inflammation at the cellular level. In this conversation, algae nutrition pioneer Catharine Arnston breaks down the shocking science behind spirulina and chlorella, why NASA compared algae nutrition to "1,000 grams of vegetables," and how these compounds may support brain health, cardiovascular function, detoxification, gut health, fertility, metabolic health, and longevity. Chase and Catharine also dive into ATP production, oxidative stress, serotonin, men's health, women's health, detoxification, inflammation, and why algae could become one of the most important functional foods of the next decade. Follow Catharine @catherinearnston Follow Energy Bits @energybits Follow Chase @chase_chewning ----- 00:00 — Intro 01:12 — What Algae Actually Is (And Why Most People Misunderstand It) 04:24 — Spirulina vs Steak: The Protein Density Debate 07:45 — 100,000 Studies on Algae & Human Health 11:16 — The Modern Nutrition Crisis Explained 12:20 — Why Most Algae Supplements Lose Their Potency 18:48 — Cardiovascular Disease, Inflammation & Spirulina Research 22:00 — How Spirulina Supports ATP & Cellular Energy 24:49 — Mitochondria, Free Radicals & The Electron Transport Chain 31:24 — Why Chronic Disease Accelerates After Age 40 36:34 — Brain Health, Neuroinflammation & Alzheimer's Prevention 39:22 — PTSD, Brain Scans & Veteran Recovery Results 41:37 — Cancer, Cellular Alkalinity & Otto Warburg's Research 43:15 — Men's Health, Iron Overload & Oxidative Stress 47:36 — Why Most Supplements Don't Work Synergistically 53:06 — Spirulina Dosage, Timing & Daily Use 55:04 — Blood Flow, Nitric Oxide & Erectile Health 57:57 — Chlorella for Detoxification, Gut Health & Recovery 59:58 — Chlorophyll, Serotonin & Gut-Brain Connection 01:04:55 — Constipation, Digestion & Natural Detox Strategies 01:06:22 — Catharine's Biological Age & Longevity Testing 01:08:46 — Shark Tank Rejection & Building EnergyBits 01:11:57 — Why Algae Is Still Misunderstood in America 01:16:23 — What "Ever Forward" Means to Catharine Arnston ----- Episode resources: Save 20% on Energy Bits with code EVERFORWARD  Watch and subscribe on YouTube Catharine first appeared in episode 474

What does it take to fold a lifelong career in cardiology into one as a successful thriller writer? Dr. Cristina LePort, accomplished cardiologist and Amazon bestselling author, captivates readers with her medical thrillers, which merge her rich medical background with gripping narratives. Cristina's novels, including Dissection, Change of Heart, and Defrosted offer a unique blend of suspense, medical insight, and ethical exploration. Her journey from Italy to the U.S. and transition from medicine to writing highlights her resilience, intellectual curiosity, and dedication to storytelling. Cristina's work stands at the crossroads of medicine and literature, engaging readers with tales that resonate with authenticity and depth. Born in Bologna, Italy, she graduated Summa cum Laude from the University of Bologna, completed her internship and Internal Medicine residency at the Long Island College Hospital in Brooklyn, NY, and her cardiology training at the VA UCLA. She is board-certified in Internal Medicine, Cardiovascular Diseases, and Nuclear Cardiology, and is the Chief Medical Officer and co-founder of Genescient, a biotech company devoted to genetic research on aging and longevity. She lives in Corona del Mar, Southern California, with her husband Peter. They have 3 children and 3 grandchildren. Her latest novel is DEFROSTED. Learn more at cristinaleport.com Intro reel, Writing Table Podcast 2024 Outro RecordingFollow the Writing Table: @writingtablepodcastEmail questions or tell us who you'd like us to invite to the Writing Table: writingtablepodcast@gmail.com.

Heart disease is NOT just a cholesterol problem. In this solo episode of The Health Fix Podcast, Dr. Jannine Krause dives into the overlooked root causes behind cardiovascular disease, elevated cholesterol, and why so many women in perimenopause and menopause are suddenly being pushed toward statins. If you've been told your cholesterol is high and immediately felt pressured into taking a statin, this episode will help you better understand the FULL picture of cardiovascular health. In This Episode You'll Learn: ✔️ Why LDL cholesterol is often misunderstood ✔️ How blood sugar dysfunction damages arteries ✔️ The connection between fatty liver disease and heart disease ✔️ Why hydration and blood viscosity matter ✔️ The role of lymphatic flow in circulation ✔️ Hormones, thyroid health, and cardiovascular risk ✔️ Natural approaches to supporting heart health ✔️ Micro-dosed GLP-1s, fiber, herbs, movement, and omega-3s ✔️ Why movement and lymphatic drainage are critical for circulation Dr. J also shares: • Her personal family history of heart disease • What she's seeing clinically in women over 40 • Why cholesterol elevations during menopause deserve a deeper look • The biggest mistakes she sees in cardiovascular care today Resources From The Show: Dr. J created a companion PDF guide that walks through her holistic cardiovascular support strategies, lymphatic drainage tools, heart-supportive nutrients, and lifestyle approaches she uses with clients in practice. ➡️ Download the FREE Wholistic Cardiovascular System Report PDF HERE Time Stamps from The Show: 00:00 Why women are being pushed toward statins 02:20 LDL cholesterol explained differently 06:20 Sticky blood, blood sugar & artery damage 08:50 Fatty liver disease and cardiovascular risk 15:00 Insulin resistance and sugar cravings 20:00 How liver congestion affects circulation 24:00 Lymphatic drainage and cardiovascular health 27:00 Blood viscosity, herbs & circulation support 35:00 Fiber, hormones & cholesterol metabolism 38:00 Magnesium, CoQ10 & heart-supportive herbs 42:00 Brain lymphatics, puffiness & acupuncture points 47:00 Red light therapy and lymphatic support 48:30 Micro-dosed GLP-1s and blood sugar balance 52:00 Sprint training and exercise for heart health 55:00 Family history, hormones & personalized prevention Supplements & Herbs Mentioned: • Magnesium • CoQ10 • Hawthorn Berry • Motherwort • Linden Flower • Omega-3s • Berberine • Red Yeast Rice • Garlic • Ginkgo • Dong Quai • Fiber • Tirzepatide • Retatrutide Connect with Dr. J: Instagram: @drjanninekrause

Hydrogen water—breakthrough or scam? Osteoporosis fixes; Nattokinase for cardiovascular prevention; Why vitamin D helps a subset of diabetics; When oral vitamin D doesn't work, sublingual D may normalize blood levels; Vitamin D found beneficial for colitis; Why fructose stokes food cravings; Flawed fluoridation study claims no IQ harms to kids.

Common medications with anticholinergic effects — including certain allergy drugs, sleep aids, and antidepressants — interfere with acetylcholine, a chemical your nervous system uses to regulate heart rhythm, blood pressure, and other automatic body functions A large study following 508,273 adults for about 14 years found that higher use of these medications was linked to significantly greater risk of cardiovascular problems such as heart failure, abnormal heart rhythms, heart attacks, and strokes Researchers observed a clear dose-response pattern: the more frequently these medications were used, the higher the risk of heart disease, with the highest exposure group showing roughly a 71% increase in cardiovascular events A separate long-term study tracking 21,636 adults found that people taking several anticholinergic medications had increased risk of developing cardiovascular disease and significantly higher death rates compared with those who took none Reducing reliance on anticholinergic medications and supporting metabolic health may help lower the drug burden on your heart and nervous system; further research is needed to confirm whether these lifestyle changes directly reduce cardiovascular risk